SAB Biotherapeutics, Inc. — 424B3 Filings
10 424B3 filings on record
This page lists all 424B3 filings submitted to the SEC by SAB Biotherapeutics, Inc. (SABSW), sorted by most recent first. Each row links to the full filing on EdgarLookup. SAB Biotherapeutics, Inc. has filed 10 424B3 documents with the SEC since 2020. To view all SEC filings by SAB Biotherapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
25-NSE
3
4
4/A
424B3
424B4
424B5
425
5
8-A12B
8-K
8-K/A
AW
CERT
CORRESP
D
DEF 14A
DEFA14A
DRSLTR
EFFECT
NT 10-K
NT 10-Q
POS AM
PRE 14A
RW
S-1
S-1/A
S-3
S-3/A
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 424B3 | 424B3 | 0001193125-25-277813 | Nov 12, 2025 | — |
| 424B3 | FORM 424B3 | 0001437749-23-005686 | Mar 7, 2023 | — |
| 424B3 | 424B3 | 0000950170-22-025415 | Nov 18, 2022 | — |
| 424B3 | 424B3 | 0000950170-22-017558 | Aug 17, 2022 | — |
| 424B3 | 424B3 | 0000950170-22-011238 | Jun 7, 2022 | — |
| 424B3 | 424B3 | 0000950170-22-009899 | May 16, 2022 | — |
| 424B3 | 424B3 | 0001193125-22-133785 | Apr 29, 2022 | — |
| 424B3 | 424B3 | 0001193125-21-369110 | Dec 29, 2021 | — |
| 424B3 | — | 0001493152-21-023619 | Sep 24, 2021 | — |
| 424B3 | — | 0001493152-21-023492 | Sep 23, 2021 | — |